Octreotide diminishes luminal nutrient transport activity, which is reversed by epidermal growth fac...
Octreotide diminishes luminal nutrient transport activity, which is reversed by epidermal growth factor
About this item
Full title
Author / Creator
Publisher
New York, NY: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York, NY: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Octreotide (SMS) is a somatostatin analogue utilized in patients with short bowel syndrome (SBS) to decrease output. It may inhibit small bowel adaptation by blocking the secretion of trophic hormones such as epidermal growth factor (EGF). This study delineates the effects of SMS and EGF on nutrient transport in SBS.
One week after 70% jejunoile...
Alternative Titles
Full title
Octreotide diminishes luminal nutrient transport activity, which is reversed by epidermal growth factor
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_78431320
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_78431320
Other Identifiers
ISSN
0002-9610
E-ISSN
1879-1883
DOI
10.1016/S0002-9610(96)00163-8
